Shinichi Takeuchi
Papers
4
Total Citations
20
H-Index
3
About
Dr. Shinichi Takeuchi is a pioneering urologic surgeon whose research focuses on advancing robotic surgical techniques and optimizing treatment strategies for prostate and bladder cancers. His major contributions center on developing and validating structured training systems to improve surgical outcomes, particularly in robot-assisted radical prostatectomy (RARP). His landmark 2022 study, with 9 citations, demonstrated that a standardized training program enabled novice surgeons at a low-volume Japanese institute to achieve perioperative and oncologic outcomes comparable to experienced surgeons—a critical step toward democratizing access to high-quality robotic surgery. Dr. Takeuchi has also explored neoadjuvant chemohormonal therapy for high-risk prostate cancer, reporting promising efficacy and safety with an LHRH antagonist and tegafur-uracil combination (5 citations). His work on clinical predictors of Grade Group upgrading from biopsy to prostatectomy specimens (3 citations) helps refine risk stratification for treatment decisions. Additionally, he introduced the “Trisection Method” for robot-assisted radical cystectomy, dividing complex procedures into manageable segments to reduce surgeon fatigue and enhance training (3 citations). Through these innovations, Dr. Takeuchi is shaping safer, more effective surgical care and training paradigms in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4